TIt is an approach that has served society well over the centuries. Yet recently it has become more controversial. Should life-saving drugs be patented? Should life forms? Should a company get private rights for software without revealing the underlying source code? Does the morass of patents and licenses in the field of biotech actually limit progress?
Amid such arguments, IBM has quietly brought forth a new idea: an “eco-patent commons” (EPC), a process to share intellectual property (IP) related to environmental and ecological technology.
There is a need. The vast majority of patenting happens in the North, whereas the rapidly industrializing South requires all the help it can get in managing environmental impacts (see figure below). The goal is to have the EPC serve as the catalyst for collaboration and innovation in addressing urgent environmental challenges.
Subscribe
Subscribe to IEMA's newsletters to receive timely articles, expert opinions, event announcements, and much more, directly in your inbox.
Posted on 27th March 2007
Latest Posts
-
IEMA appoints two new Board Directors
- 28th March 2024 -
Impact Assessment Network Volunteers receive International Association of Impact Assessment (IAIA) Regional Award
- 20th March 2024 -
IEMA launches digital campaign to share knowledge and inspire action in sustainability
- 6th March 2024 -
IEMA comments on 2023 being hottest year on record
- 9th January 2024 -
IEMA reacts to COP28 agreement to transition away from fossil fuels
- 13th December 2023 -
New IEMA social sustainability steering group – express your interest in joining
- 24th November 2023